Search Results - "Mathiot C"

Soluble CD16 in Plasma Cell Dyscrasias.

Authors: Mathiot, C. Galon, J. Tartour, E. et al.

Source: Leukemia & Lymphoma. Feb99, Vol. 32 Issue 5/6, p467. 8p. 3 Charts.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

Authors: Bidard, F.-C. Mathiot, C. Degeorges, A. et al.

Source: Annals of Oncology. Sep2010, Vol. 21 Issue 9, p1765-1771. 7p. 3 Charts, 2 Graphs.

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer.

Authors: Bidard, F.-C. Mathiot, C. Delaloge, S. et al.

Source: Annals of Oncology. Apr2010, Vol. 21 Issue 4, p729-733. 5p. 2 Charts, 1 Graph.

Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma.

Authors: Farace, F. Mathiot, C. Brandely, M. et al.

Source: Clinical & Experimental Immunology. Nov1990, Vol. 82 Issue 2, p194-199. 6p.

Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons.

Authors: Bauvois, B Dumont, J Mathiot, C et al.

Source: Leukemia (08876924). May2002, Vol. 16 Issue 5, p791. 8p.

HIV seroprevalence and male to female ratio in central Africa.

Authors: Mathiot, C C Lepage, C Chouaib, E et al.

Source: Lancet. 3/17/1990, Vol. 335 Issue 8690, p672-672. 1p.

Prognostic utility of intact immunoglobulin Ig'κ/Ig'λ ratios in multiple myeloma patients.

Authors: Bradwell A Harding S Fourrier N et al.

Source: Leukemia (08876924). Jan2013, Vol. 27 Issue 1, p202-207. 6p.

Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials.

Authors: Moreau, P. Attal, M. Garban, F. et al.

Source: Leukemia (08876924). Sep2007, Vol. 21 Issue 9, p2020-2024. 5p. 1 Chart, 6 Graphs.

Mosquito vectors of the 1998–1999 outbreak of Rift Valley Fever and other arboviruses (Bagaza, Sanar, Wesselsbron and West Nile) in Mauritania and Senegal.

Authors: Diallo, M. Nabeth, P. Ba, K. et al.

Source: Medical & Veterinary Entomology. Jun2005, Vol. 19 Issue 2, p119-126. 8p.

Peripheral blood stem cell collection in 24 low-weight infants: experience of a single centre.

Authors: Orbach, D Hojjat-Assari, S Doz, F et al.

Source: Bone Marrow Transplantation. 2/1/2003, Vol. 31 Issue 3, p171. 4p.

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings.

Authors: Tartour, E Mehtali, M Sastre-Garau, X et al.

Source: British Journal of Cancer. 12/1/2000, Vol. 83 Issue 11, p1454. 8p.

Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005–01 trial.

Authors: Moreau, P. Hulin, C. Marit, G. et al.

Source: Leukemia (08876924). Jun2010, Vol. 24 Issue 6, p1233-1235. 3p. 2 Charts.

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma.

Authors: Fouquet, G. Pegourie, B. Macro, M. et al.

Source: Annals of Oncology. May2016, Vol. 27 Issue 5, p902-907. 6p. 2 Charts, 1 Graph.

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial.

Authors: Bidard, F. C. Huguet, F. Louvet, C. et al.

Source: Annals of Oncology. Aug2013, Vol. 24 Issue 8, p2057-2061. 5p. 3 Charts, 1 Graph.

Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.

Authors: Attal M Lauwers-Cances V Marit G et al.

Source: New England Journal of Medicine. 5/10/2012, Vol. 366 Issue 19, p1782-1791. 10p.

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients.

Authors: Pierga, J.-Y. Hajage, D. Bachelot, T. et al.

Source: Annals of Oncology. Mar2012, Vol. 23 Issue 3, p618-624. 7p. 2 Charts, 4 Graphs.

Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience.

Authors: Avet-Loiseau, H Roussel, M Campion, L et al.

Source: Leukemia (08876924). Jan2012, Vol. 26 Issue 1, p158-159. 2p. 2 Graphs.